DRIO - NASDAQ
DarioHealth Corp.
$7.65
+3.7%DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
At a Glance
Live SnapshotDarioHealth Corp. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
DarioHealth Corp. Income Statement
DRIO • NASDAQ
| DarioHealth Corp. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||
22.4M | 27M | 20.4M | 27.7M | 20.5M | 7.6M | 7.6M | 7.4M | 5.2M | 2.8M | 823K | 51K | 0.0 | 0.0 | |
GROSS PROFIT | ||||||||||||||
(9.7M) | (13.8M) | (14.4M) | (18M) | (12.4M) | (5.1M) | (5M) | (5.6M) | (3.9M) | (3.4M) | (1.7M) | (2.3M) | (13.6M) | (0.0) | |
12.7M | 13.3M | 6M | 9.7M | 8.1M | 2.5M | 2.6M | 1.8M | 1.3M | -561K | -855K | -2.2M | -13.6M | 0.0 | |
OPERATING INCOME | ||||||||||||||
(49.3M) | (71M) | (62.2M) | (66.5M) | (84.6M) | (32.4M) | (20.3M) | (19.5M) | (15.7M) | (10.3M) | (6.8M) | (8.6M) | (13.6M) | (4M) | |
(35.5M) | (46.8M) | (41.8M) | (46.8M) | (62.4M) | (28M) | (16.6M) | (15.8M) | (12.4M) | (8.1M) | (4.3M) | (4.7M) | (8.6M) | (2.5M) | |
(13.8M) | (24.2M) | (20.2M) | (19.6M) | (17.2M) | (4.4M) | (3.7M) | (3.7M) | (3.3M) | (2.2M) | (2.6M) | (3.9M) | (4.9M) | (1.5M) | |
-36.7M | -57.7M | -56.2M | -56.8M | -76.5M | -29.9M | -17.7M | -17.7M | -14.4M | -11.1M | -7.7M | -11.4M | -13.6M | -4M | |
PRE-TAX INCOME | ||||||||||||||
(3.4M) | (96K) | (645K) | (2.7M) | (84K) | (49K) | (27K) | (18K) | (171K) | (20K) | (22K) | (3.7M) | (75.8K) | (0.0) | |
-2.4M | 1M | 1.2M | -2.2M | -40K | 12K | -11K | -18K | -171K | -20K | -22K | -3.7M | 0.0 | 0.0 | |
(0.0) | (0.0) | (128K) | (0.0) | (5M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-5M | 13.1M | -3.2M | -5.4M | -235K | 458K | -31K | -115K | -1.3M | 214K | 556K | -1.5M | -369.8K | -1.7M | |
-41.6M | -44.6M | -59.4M | -62.2M | -76.7M | -29.4M | -17.7M | -17.8M | -15.7M | -10.9M | -7.1M | -12.9M | -13.9M | -5.7M | |
NET INCOME | ||||||||||||||
(105K) | -1.9M | (64K) | (4K) | (32K) | (0.0) | (0.0) | -115K | (0.0) | (55K) | (0.0) | (0.0) | (0.0) | (0.0) | |
-41.7M | -42.7M | -59.4M | -62.2M | -76.8M | -29.4M | -17.8M | -17.8M | -15.7M | -10.9M | -7.1M | -12.9M | -13.9M | -5.7M |
SEC Filings
DRIO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 13, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 | |
S-3 S-3 N/A | March 19, 2026 | March 19, 2026 | ||
10-K 10-K 2025 FY FY | March 19, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 02, 2026 | February 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 29, 2026 | January 29, 2026 | 2026 | |
S-3/A S-3/A (Amended) N/A | December 29, 2025 | December 29, 2025 | ||
DEF 14A DEF 14A 2026 N/A | December 22, 2025 | January 29, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 13, 2025 | September 30, 2025 | 2025 |
Related Guides
Continue your DRIO research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.